Synonyms: BAY069 | compound 36a [PMID: 36261130]
Compound class:
Synthetic organic
Comment: BAY-069 is a small molecule inhibitor of branched chain amino acid transaminases 1 and 2 (BCAT1/2) [1]. It is an experimental tool compound for in vitro and in vivo studies. BAY-069 is available from the Structural Genomics Consortium in support of open science [2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Günther J, Hillig RC, Zimmermann K, Kaulfuss S, Lemos C, Nguyen D, Rehwinkel H, Habgood M, Lechner C, Neuhaus R et al.. (2022)
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. J Med Chem, 65 (21): 14366-14390. [PMID:36261130] |
2. SGC.
Overview for BAY-069 an inhibitor of BCAT1, BCAT2. Accessed on 21/10/2022. Modified on 04/08/2023. thesgc.org, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-069. DOI: 10.6019/CHEMBL4507325 |
3.
Data for DCP probe BAY-069.
Accessed on 21/10/2022. Modified on 21/10/2022. www.ebi.ac.uk/chembl, . DOI: 10.6019/CHEMBL4507325 |